The Future of Glucagon-Like Peptide-1 Receptor Agonists In Cardiovascular-Kidney-Metabolic Diseases
Nephrol Dial Transplant
.
2025 Jan 11:gfaf008.
doi: 10.1093/ndt/gfaf008.
Online ahead of print.
Authors
Matias Trillini
1
,
Trond Geir Jenssen
2
3
,
William Patrick Martin
4
,
Enrique Morales
5
6
7
Affiliations
1
Istituto di Ricerche Farmacologiche Mario Negri IRCCS.
2
Department of Transplantation Medicine, Section of Nephrology, Oslo University Hospital Rikshospitalet.
3
Institute of Clinical Medicine, University of Oslo, both in Oslo, Norway.
4
Department of Nephrology, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, D07 R2WY, Ireland.
5
Department of Nephrology, Hospital Universitario 12 de Octubre.
6
Research Institute of University Hospital "12 de Octubre" (i+12).
7
Department of Medicine, Complutense University, all in Madrid, Spain.
PMID:
39799384
DOI:
10.1093/ndt/gfaf008
No abstract available